Prognostic Nutritional Index enhances risk stratification and predicts progression-free survival in upper tract urothelial carcinoma

预后营养指数可增强风险分层并预测上尿路尿路上皮癌的无进展生存期

阅读:2

Abstract

BACKGROUND: The management of upper tract urothelial carcinoma (UTUC) after radical nephroureterectomy (RNU) is hampered by heterogeneous outcomes and a lack of robust, integrative biomarkers. The Prognostic Nutritional Index (PNI), reflecting both nutritional status and systemic immunity, has emerged as a prognostic tool in various cancers, but its utility in UTUC remains underexplored. OBJECTIVE: To comprehensively evaluate the prognostic value of preoperative PNI and to develop a validated nomogram for predicting progression-free survival (PFS) in UTUC patients undergoing RNU. METHODS: In this retrospective cohort study, 200 consecutive UTUC patients treated with RNU (2016–2020) were analyzed. The PNI was calculated as 10 × serum albumin (g/dL) + 0.005 × total lymphocyte count (per μL). Receiver operating characteristic (ROC) curve analysis determined the optimal PNI cut-off. Survival analyses were performed using Kaplan–Meier and Cox proportional hazards models. A nomogram integrating independent predictors was developed and subjected to internal validation with bootstrapping, assessing discrimination, calibration, and clinical utility. RESULTS: The optimal PNI cut-off was 46.0, demonstrating high predictive accuracy for recurrence (area under the curve [AUC] = 0.866). Patients with low PNI (< 46.0) had significantly inferior PFS (median PFS: 32 vs. 58 months; log-rank P = 0.002). Multivariate analysis identified low PNI (Hazard Ratio [HR] = 1.96, 95% Confidence Interval [CI]: 1.33–2.88, P < 0.001), tumor size ≥ 3 cm (HR = 1.84, 95% CI: 1.06–3.20, P = 0.030), multifocality (HR = 1.80, 95% CI: 1.09–2.97, P = 0.021), high-grade pathology (HR = 1.68, 95% CI: 1.03–2.73, P = 0.037), and advanced T stage (pT3/T4) as independent predictors of poor PFS. The resultant nomogram exhibited good discriminative ability, with an AUC of 0.903 for predicting 3-year PFS, and provided a positive net benefit on decision curve analysis. CONCLUSION: Preoperative PNI may serve as a potent, independent prognostic factor for UTUC. The integrated nomogram demonstrates good predictive accuracy and facilitates personalized risk assessment, potentially guiding adjuvant therapy decisions and postoperative surveillance strategies. The modifiable nature of PNI also opens avenues for nutritional and immunomodulatory interventions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12672-026-04676-z.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。